An NIH-supported post-doctoral position is available immediately for a recent Ph.D. graduate in microbiology, cell biology, or a related field to study interactions between bacterial protein toxins and eukaryotic cells. Applicants should have experience working in BSL2 (or higher).

We investigate interactions between pathogenic bacteria and their hosts, emphasizing protein toxins. Current studies focus on toxins produced by Clostridium perfringens and Helicobacter pylori and suspected toxins from other pathogenic bacteria. Using high-throughput screens and molecular genetic, biochemical, and cell biological techniques, we seek to understand the molecular events that contribute to toxin activity and to develop inhibitors to treat disease.

To apply: To apply: Interested applicants should send 1) cover letter, 2) curriculum vitae and 3) contact details of three references to: Mark McClain at mark.mcclain@vanderbilt.edu.

The Department of Medicine at Vanderbilt University was established in 1925 and currently has over 600 faculty assigned to 12 traditional divisions and several interdisciplinary research centers. The Department has a diverse research portfolio currently supported by more than $140,000,000 of annual funding. In 2008, it was ranked 5th in NIH funding for research among all Departments of Medicine in US medical schools. Vanderbilt University has been named one of the top 100 best places to work in the United States in Fortune magazine’s 2009 survey, and it is the first educational institution to ever be named to the list.